429 related articles for article (PubMed ID: 16906535)
21. Reduced adult neurogenesis and altered emotional behaviors in autoimmune-prone B-cell activating factor transgenic mice.
Crupi R; Cambiaghi M; Spatz L; Hen R; Thorn M; Friedman E; Vita G; Battaglia F
Biol Psychiatry; 2010 Mar; 67(6):558-66. PubMed ID: 20185032
[TBL] [Abstract][Full Text] [Related]
22. B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus.
Parameswaran R; Ben David H; Sharabi A; Zinger H; Mozes E
Clin Immunol; 2009 May; 131(2):223-32. PubMed ID: 19188092
[TBL] [Abstract][Full Text] [Related]
23. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.
Gross JA; Johnston J; Mudri S; Enselman R; Dillon SR; Madden K; Xu W; Parrish-Novak J; Foster D; Lofton-Day C; Moore M; Littau A; Grossman A; Haugen H; Foley K; Blumberg H; Harrison K; Kindsvogel W; Clegg CH
Nature; 2000 Apr; 404(6781):995-9. PubMed ID: 10801128
[TBL] [Abstract][Full Text] [Related]
24. Double knockout mice show BASH and PKCdelta have different epistatic relationships in B cell maturation and CD40-mediated activation.
Nojima T; Hayashi K; Goitsuka R; Nakayama K; Nakayama K; Kitamura D
Immunol Lett; 2006 May; 105(1):48-54. PubMed ID: 16481047
[TBL] [Abstract][Full Text] [Related]
25. BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses.
Ye Q; Wang L; Wells AD; Tao R; Han R; Davidson A; Scott ML; Hancock WW
Eur J Immunol; 2004 Oct; 34(10):2750-9. PubMed ID: 15368291
[TBL] [Abstract][Full Text] [Related]
26. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome.
Szodoray P; Jonsson R
Scand J Immunol; 2005 Nov; 62(5):421-8. PubMed ID: 16305638
[TBL] [Abstract][Full Text] [Related]
27. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses.
Xu S; Lam KP
Mol Cell Biol; 2001 Jun; 21(12):4067-74. PubMed ID: 11359913
[TBL] [Abstract][Full Text] [Related]
28. A Trypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells.
Montes CL; Acosta-Rodríguez EV; Mucci J; Zuniga EI; Campetella O; Gruppi A
Eur J Immunol; 2006 Jun; 36(6):1474-85. PubMed ID: 16688679
[TBL] [Abstract][Full Text] [Related]
29. BAFF-driven autoimmunity requires CD19 expression.
Fairfax KA; Tsantikos E; Figgett WA; Vincent FB; Quah PS; LePage M; Hibbs ML; Mackay F
J Autoimmun; 2015 Aug; 62():1-10. PubMed ID: 26103922
[TBL] [Abstract][Full Text] [Related]
30. Expression of lymphotoxin beta governs immunity at two distinct levels.
Junt T; Tumanov AV; Harris N; Heikenwalder M; Zeller N; Kuprash DV; Aguzzi A; Ludewig B; Nedospasov SA; Zinkernagel RM
Eur J Immunol; 2006 Aug; 36(8):2061-75. PubMed ID: 16841297
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy.
Yoshimoto K; Takahashi Y; Ogasawara M; Setoyama Y; Suzuki K; Tsuzaka K; Abe T; Takeuchi T
Int Immunol; 2006 Jul; 18(7):1189-96. PubMed ID: 16740602
[TBL] [Abstract][Full Text] [Related]
32. Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs.
Wilhelm P; Riminton DS; Ritter U; Lemckert FA; Scheidig C; Hoek R; Sedgwick JD; Körner H
Eur J Immunol; 2002 Jul; 32(7):1993-2003. PubMed ID: 12115620
[TBL] [Abstract][Full Text] [Related]
33. TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma.
Batten M; Fletcher C; Ng LG; Groom J; Wheway J; Laâbi Y; Xin X; Schneider P; Tschopp J; Mackay CR; Mackay F
J Immunol; 2004 Jan; 172(2):812-22. PubMed ID: 14707051
[TBL] [Abstract][Full Text] [Related]
34. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.
Daridon C; Pers JO; Devauchelle V; Martins-Carvalho C; Hutin P; Pennec YL; Saraux A; Youinou P
Arthritis Rheum; 2006 Jul; 54(7):2280-8. PubMed ID: 16802367
[TBL] [Abstract][Full Text] [Related]
35. BAFF costimulation of Toll-like receptor-activated B-1 cells.
Ng LG; Ng CH; Woehl B; Sutherland AP; Huo J; Xu S; Mackay F; Lam KP
Eur J Immunol; 2006 Jul; 36(7):1837-46. PubMed ID: 16791880
[TBL] [Abstract][Full Text] [Related]
36. BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome.
d'Arbonneau F; Pers JO; Devauchelle V; Pennec Y; Saraux A; Youinou P
Arthritis Rheum; 2006 Jan; 54(1):115-26. PubMed ID: 16385503
[TBL] [Abstract][Full Text] [Related]
37. BAFF: a fundamental survival factor for B cells.
Mackay F; Browning JL
Nat Rev Immunol; 2002 Jul; 2(7):465-75. PubMed ID: 12094221
[TBL] [Abstract][Full Text] [Related]
38. The role of APRIL and BAFF in lymphocyte activation.
Schneider P
Curr Opin Immunol; 2005 Jun; 17(3):282-9. PubMed ID: 15886118
[TBL] [Abstract][Full Text] [Related]
39. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers.
Mackay F; Tangye SG
Curr Opin Pharmacol; 2004 Aug; 4(4):347-54. PubMed ID: 15251127
[TBL] [Abstract][Full Text] [Related]
40. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.
Mackay F; Silveira PA; Brink R
Curr Opin Immunol; 2007 Jun; 19(3):327-36. PubMed ID: 17433868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
